logo
Trump's doctors say his swollen legs typical of age

Trump's doctors say his swollen legs typical of age

Perth Now17-07-2025
US President Donald Trump has been diagnosed with a "common" vein condition after being evaluated by his doctor over swelling in his lower legs, the White House said.
Reading a letter from Trump's physician, Leavitt said at a press briefing that an ultrasound on the president's legs "revealed chronic venous insufficiency ... a common condition, particularly in individuals over the age of 70."
Leavitt said there was "no evidence" of more serious conditions such as deep vein thrombosis or arterial disease. Additional exams identified "no signs of heart failure, renal impairment or systemic illness," Leavitt said.
Leavitt said Trump was not experiencing discomfort due to the condition.
According to the National Library of Health's MedlinePlus website, "Venous insufficiency is a condition in which the veins have problems sending blood from the legs back to the heart."
The condition "tends to get worse over time" but "can be managed if treatment is started in the early stated stages," the website says.
Leavitt also said that Trump had experienced bruising on the back of his hand.
She described this as "consistent with minor soft tissue irritation from frequent hand shaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen".
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump takes aim at ‘foreign freeloading nations' over drug prices in new threat to PBS
Trump takes aim at ‘foreign freeloading nations' over drug prices in new threat to PBS

The Age

time2 days ago

  • The Age

Trump takes aim at ‘foreign freeloading nations' over drug prices in new threat to PBS

Washington: US President Donald Trump has blamed 'foreign freeloading nations' for the high drug prices faced by Americans and told pharmaceutical firms to negotiate harder with other countries, in a new threat to programs such as Australia's Pharmaceutical Benefits Scheme. Trump issued letters to the bosses of 17 drug firms on Thursday (Friday AEST) demanding they extend 'most favoured nation' pricing to the US Medicaid scheme, and guarantee such pricing for new drugs. It means other comparable, high-income nations could not be offered cheaper prices than the US. 'Domestic MFN pricing will require you, and all manufacturers, to negotiate harder with foreign freeloading nations,' Trump wrote in the letters. 'US trade policy will endeavour to support this. However, increased revenues abroad must be repatriated to lower drug prices for American patients and taxpayers through an explicit agreement with the United States.' The letters were sent to major drugmakers including Pfizer, Eli Lilly, AstraZeneca and Johnson & Johnson, and published on Trump's social media. They did not mention Australia but referred to putting 'an end to the free ride of American innovation by European and other developed nations'. Under the PBS, Australians can buy life-saving drugs worth thousands of dollars for as little as $31.60 a script after the government negotiates with the drug company to secure a lower price based on buying in bulk. Trump's letter makes explicit instructions to drug firms to 'negotiate harder' and return those extra profits to American patients and taxpayers.

‘Foreign freeloading nations': Trump takes aim at drug companies in latest threat to PBS
‘Foreign freeloading nations': Trump takes aim at drug companies in latest threat to PBS

The Age

time2 days ago

  • The Age

‘Foreign freeloading nations': Trump takes aim at drug companies in latest threat to PBS

Washington: US President Donald Trump has blamed 'foreign freeloading nations' for the high drug prices faced by Americans and told pharmaceutical firms to negotiate harder with other countries, in a new threat to programs such as Australia's Pharmaceutical Benefits Scheme. Trump issued letters to the bosses of 17 drug firms on Thursday (Friday AEST) demanding they extend 'most favoured nation' pricing to the US Medicaid scheme, and guarantee that pricing level for new drugs. It means other comparable, high-income nations could not be offered cheaper prices than the US. 'Domestic MFN pricing will require you, and all manufacturers, to negotiate harder with foreign freeloading nations,' Trump wrote in the letters. 'US trade policy will endeavour to support this. However, increased revenues abroad must be repatriated to lower drug prices for American patients and taxpayers through an explicit agreement with the United States.' The letters were sent to major drugmakers including Pfizer, Eli Lilly, AstraZeneca and Johnson & Johnson, and published on Trump's social media. Loading They did not mention Australia but referred to putting 'an end to the free ride of American innovation by European and other developed nations'. Under the PBS, Australians can buy life-saving drugs worth thousands of dollars for as little as $31.60 a script after the government negotiates with the drug company to secure a lower price based on buying in bulk. Trump's letter makes explicit instructions to drug firms to 'negotiate harder' and return those extra profits to American patients and taxpayers.

‘Foreign freeloading nations': Trump takes aim at drug companies in latest threat to PBS
‘Foreign freeloading nations': Trump takes aim at drug companies in latest threat to PBS

Sydney Morning Herald

time2 days ago

  • Sydney Morning Herald

‘Foreign freeloading nations': Trump takes aim at drug companies in latest threat to PBS

Washington: US President Donald Trump has blamed 'foreign freeloading nations' for the high drug prices faced by Americans and told pharmaceutical firms to negotiate harder with other countries, in a new threat to programs such as Australia's Pharmaceutical Benefits Scheme. Trump issued letters to the bosses of 17 drug firms on Thursday (Friday AEST) demanding they extend 'most favoured nation' pricing to the US Medicaid scheme, and guarantee that pricing level for new drugs. It means other comparable, high-income nations could not be offered cheaper prices than the US. 'Domestic MFN pricing will require you, and all manufacturers, to negotiate harder with foreign freeloading nations,' Trump wrote in the letters. 'US trade policy will endeavour to support this. However, increased revenues abroad must be repatriated to lower drug prices for American patients and taxpayers through an explicit agreement with the United States.' The letters were sent to major drugmakers including Pfizer, Eli Lilly, AstraZeneca and Johnson & Johnson, and published on Trump's social media. Loading They did not mention Australia but referred to putting 'an end to the free ride of American innovation by European and other developed nations'. Under the PBS, Australians can buy life-saving drugs worth thousands of dollars for as little as $31.60 a script after the government negotiates with the drug company to secure a lower price based on buying in bulk. Trump's letter makes explicit instructions to drug firms to 'negotiate harder' and return those extra profits to American patients and taxpayers.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store